CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Safety and pharmacokinetics of CXCR4 peptide antagonist, LY2510924, in combination with durvalumab in advanced refractory solid tumors
Authors
Anis A. Khan
Hedy Kindler
+10Â more
Mythili Koneru
Wells Messersmith
Mark H. O\u27Hara
Sheng-Bin Peng
Celine Pitou
Anna M. Szpurka
Burkhard Vangerow
Dan Wang
Andrea Wang-Gillam
Wei Zhang
Publication date
1 January 2020
Publisher
Digital Commons@Becker
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Digital Commons@Becker
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:digitalcommons.wustl.edu:o...
Last time updated on 21/11/2020